Related Experiment Video
Updated: May 28, 2026

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
Published on: April 26, 2017
Alternative splicing in oncogenic kinases: from physiological functions to cancer
Sabine Druillennec1, Coralie Dorard, Alain Eychène
1Institut Curie, 91405 Orsay, France.
Abstract:
Among the 518 protein kinases encoded by the human kinome, several of them act as oncoproteins in human cancers. Like other eukaryotic genes, oncogenes encoding protein kinases are frequently subjected to alternative splicing in coding as well as noncoding sequences. In the present paper, we will illustrate how alternative splicing can significantly impact on the physiological functions of oncogenic protein kinases, as demonstrated by mouse genetic model studies. This includes examples of membrane-bound tyrosine kinases receptors (FGFR2, Ret, TrkB, ErbB4, and VEGFR) as well as cytosolic protein kinases (B-Raf). We will further discuss how regular alternative splicing events of these kinases are in some instances implicated in oncogenic processes during tumor progression (FGFR, TrkB, ErbB2, Abl, and AuroraA). Finally, we will present typical examples of aberrant splicing responsible for the deregulation of oncogenic kinases activity in cancers (AuroraB, Jak2, Kit, Met, and Ron).
Insights
Alternative splicing significantly impacts oncogenic protein kinase function in cancer. This review highlights how normal and aberrant splicing events contribute to tumor progression and kinase deregulation.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- The human kinome comprises 518 protein kinases, with several functioning as oncoproteins in human cancers.
- Like other eukaryotic genes, oncogenes encoding protein kinases undergo alternative splicing in both coding and noncoding regions.
Purpose of the Study:
- To illustrate the significant impact of alternative splicing on the physiological functions of oncogenic protein kinases.
- To discuss the role of regular and aberrant alternative splicing in cancer development and progression.
Main Methods:
- Review of existing literature and studies, including mouse genetic models.
- Analysis of specific examples of membrane-bound tyrosine kinases and cytosolic protein kinases.
- Examination of alternative splicing events implicated in oncogenic processes and kinase deregulation.
Main Results:
- Alternative splicing affects the physiological functions of oncogenic protein kinases, as shown in mouse models.
- Regular alternative splicing events can be implicated in oncogenic processes during tumor progression.
- Aberrant splicing events are responsible for the deregulation of oncogenic kinase activity in cancers.
Conclusions:
- Alternative splicing is a critical mechanism influencing the function of oncogenic protein kinases.
- Both normal and aberrant splicing play roles in cancer development, progression, and kinase activity deregulation.
Related Concept Videos
RNA Splicing
RNA Splicing
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

